Skip to main content

Table 2 Summary of representative studies evaluating the biocompatibility and toxicity of some PLGA-based NPs

From: Nanotoxicological profiles of clinically approved nanoplatforms

Formulation composition

Preparation method

Dose (administration route)

Animal/cell type

Cell/tissue target

Biocompatibility-/toxicity-related outcomes

References

In vitro studies

Fluorescein amine-labelled PLGA mixed with ε-caprolactone–PEG copolymers

Nanoprecipitation technique–solvent evaporation

18–180 μg/mL

L929 cell line

Mouse fibroblasts

PLGA-based NPs exhibited no changes in fibroblasts morphology and confluent monolayer after 48-h incubation, while dendrimers led to altered morphology and detachment in a dose-dependent way

Do et al. [30]

Gold NPs-coated polydopamine-modified PLGA capsule hybrid

Double emulsion, solvent evaporation

10–1000 μg/mL

ECA-109 cell line

Human oesophageal cancer cell

No remarkable cytotoxicity: cell viability was same as the control cells treated with PBS over 24 h

Xi et al. [149]

Monomethoxy-PEG-PLGA-poly(L-lysine) NPs

One-step oil-in-water emulsion, solvent evaporation

10–1000 μM

RAW 264.7, Huh7 and L02 cells

Murine macrophage, human hepatic carcinoma and normal embryo liver cells

No effect on cell membrane integrity, protein synthesis and chromatin stability, except dose-dependent and time-dependent increase in the content of reactive oxygen species. No significant induction of inflammatory cytokines

He et al. [55]

folic-acid-grafted-PEG-PLGA NPs co-loaded with cisplatin and paclitaxel

One-step oil-in-water emulsion, solvent evaporation

0.01–1 mg/mL

New Zealand white rabbits’ blood; M109 and A549 cells

Rabbit erythrocyte, murine and human lung carcinoma cell

Drug-free NPs exhibited no overt cytotoxicity, haemolysis, blood clotting or complement activation

He et al. [53]

Amphotericin B-loaded PLGA NPs decorated with dimercaptosuccinic acid ligand

Water-in-oil emulsification, solvent evaporation

1.56–600 μg/mL

Human blood and peritoneal tissues

Erythrocyte and peritoneal macrophages

Drug-loaded NPs were less haemolytic than plain drug. NPs showed no cytotoxicity, while free drug was toxic

Souza et al. [130]

Biotin/lactobionic acid-modified PEG-PLGA-PEG NPs co-loaded with curcumin and 5-fluorouracil

Nanoprecipitation technique–solvent evaporation

50–800 μg/mL

Hep G2 and HL 7702 cells

Human hepatocytes and hepatoma cells

Unlike drug-loaded NPs, the blank NPs showed no overt cytotoxicity after 48 h of incubation

Ni et al. [97]

Didodecyldimethylammonium bromide (DMAB)-stabilized PLGA modified with polyvinyl alcohol (PVA) or PEG

One-step oil-in-water emulsion, solvent evaporation

0.5–1000 μg/mL

Caco-2 cell line

Human epithelial colorectal adenocarcinoma cells

DMAB-PLGA NPs modified with PVA or PEG showed no cytotoxicity, while unmodified NPs induced significant concentration-dependent necrosis, apoptosis and chromatin disturbance

Gossmann et al. [46]

PLGA-poly(3-hydroxybutyrate) nanocomposite extract

Needle-punching non-woven fabric synthesis catalysed by Zr(AcAc)4

Not indicated

Fibroblast-like cell line L929

Mouse fibroblast

No cytotoxic or genotoxic effects were observed following 72 h of incubation

Krucinska et al. [73]

PLGA NPs loaded with TRITC-in-polyethyleneimine

Double emulsion, solvent evaporation

Not indicated

Male and female gametes

Sperms, oocytes

No distinct morphological, chromosomal abnormalities, transgenerational effects or genetic aberrations were observed

Kim et al. [70]

PLGA-(poly-L-orithine/fucoidan) core–shell NPs

One-step oil-in-water emulsion, solvent evaporation

5–100 µg/mL

MCF-10A cell line

Breast epithelium cells and rabbit blood cells

Cell morphology was unchanged, but proliferation pattern was affected in a time-dependent way. Haemolysis rates increased with NPs concentrations

Cai et al. [21]

PLGA NPs

Nanoprecipitation, solvent evaporation

0.1–0.4 mg/ml

Primary human myoblasts and myotubes

Skeletal tissues

PLGA NPs did not decrease cell viability, while liposomes and silica NPs showed concentration-dependent and time-dependent decrease in cell viability

Guglielmi et al. [49]

PEG-PLGA, PEG-poly(L-lactide) (PLA) and PEG-PLA-PEG NPs

One-step oil-in-water emulsion, solvent evaporation

0.05–1 mg/ml

Fibroblast-like cell line L-929 and human umbilical vein endothelial cell

Mouse fibroblasts, blood, human macrophages and human vascular endothelium

No significant cytotoxicity observed. Adverse effects of PEG-PLGA NPs on haemolysis and inflammatory cytokines release were the highest while PEG-PLA-PEG NPs’ were the lowest

Shen et al. [125]

PLGA NPs loaded with Chondroitinase ABC (ChABC)

Double emulsion, solvent evaporation

1500–6000 µg/mL

Olfactory ensheathing cells

Rat olfactory mucosa

Following 48 h of incubation, there were no significant differences between the control and NP-treated cell viability

Azizi et al. [11]

Chitosan-coated PLGA nanoparticles loaded with bevacizumab

One-step oil-in-water emulsion, solvent evaporation

Not reported

Fertilized fresh hen’s eggs

Hen’s egg chorioallantoic membrane

NPs formulation was non-irritant and tolerated to chorioallantoic membrane after

Pandit et al. [104]

Cell-penetrating peptides decorating DNA-loaded PLGA nanoparticles

Double emulsion-solvent evaporation method

0.075–1.2 mg/mL

A549 and Beas-2B cells

Lung tissues

After 24-h incubation of NPs with cells, there was no change in mitochondrial activity and membrane integrity

In addition, the inflammatory response and levels of apoptosis were significantly lower, and there was no activation of caspase-3

Dos Reis et al. [32]

In vivo studies

Monomethoxy-PEG-PLGA-poly(L-lysine) NPs

One-step oil-in-water emulsion, solvent evaporation

10–1000 μM

Zebrafish embryos

Heart

No effect on embryonic heartbeat rate, malformation or survival. At extreme concentrations (> 500 μM), NPs induced reactive oxygen species production at early stage of embryonic development

He et al. [54]

PLGA-poly(3-hydroxybutyrate) nanocomposite bone implant

Needle-punching non-woven fabric synthesis catalysed by Zr(AcAc)4

Surgical femur implantation

New Zealand breed male and female rabbits

Blood, RES organs, stomach, small and large intestine, testes, uterus, heart

The blood cells remained unchanged. No significant differences between enzymes values from the test and control groups following 180 days of implantation

Krucinska et al. [73]

Biotin/lactobionic acid-modified PEG-PLGA-PEG NP

Nanoprecipitation, solvent evaporation

200 mg/kg every 2 h (IV)

Female nude balb/c mice

Liver, spleen, kidneys, lunges and heart

No obvious signs of cellular or organ injury or inflammation were observed, and no death was recorded after injection of up to 2000 mg/kg in total

Ni et al. [97]

PLGA NPs loaded with TRITC-in-polyethyleneimine

Double emulsion-solvent evaporation method

Not indicated

ICR mice

Murine embryos

No influence on embryo development to the blastocyst

Kim et al. [70]

Amphotericin B-loaded PLGA and PLGA-PEG blend NPs

One-step oil-in-water emulsion, solvent evaporation

10 mg/kg/day (oral or IP)

Male Wistar rat

Liver, kidneys and blood cells

Biochemical and histopathological parameters remained unchanged after 7 days of treatment. Unlike the plain drug, NPs showed no blood cell damage

Moraes Moreira Carraro et al. [93]

Amphotericin B-loaded PLGA NPs decorated with dimercaptosuccinic acid ligand

Water-in-oil emulsification, solvent evaporation

6 or 30 mg/kg/day (IP)

Healthy balb/c or Swiss mice

Blood, peritoneal, bone marrow cells

No significant difference between the DNA from mice treated with NPs and PBS, while control (cyclophosphamide) caused DNA damage. NPs showed similar neutrophils, leucocytes and monocytes as PBS, unlike the plain drug

Souza et al. [130]

PLGA-(poly-l-orithine/fucoidan) core–shell NPs

One-step oil-in-water emulsion, solvent evaporation

300 mg/kg (IP)

SPF mice

Liver and kidney

NPs showed no significant differences with negative control in body weight and histological parameters. No death or apparent toxicity was observed

Cai et al. [21]

PEG-PLGA, PEG-poly(L-lactide) (PLA) and PEG-PLA-PEG NPs

One-step oil-in-water emulsion, solvent evaporation

0.05–1 mg/ml

Zebrafish embryos

Heart and yolk sac

The concentration-dependent adverse effects of PEG-PLGA NPs on embryo survival and growth were the highest, while PEG-PLA-PEGs were lowest

Shen et al. [125]

PLGA NPs and surface-modified PLGA chitosan NPs

One-step oil-in-water emulsion, solvent evaporation

12 mg/kg/day (oral)

F344 rats

Spleen, kidney, liver, lung, brain, intestine, heart

No significant histological changes seen in tested organs, except for intestine and liver. Body weight remained unchanged

Navarro et al. [96]

Doxorubicin-loaded PLGA nanoparticles coated with poloxamer 188

Double emulsion-solvent evaporation technique

0.15–0.22 mg/kg/day (IV)

Chinchilla rabbits

Blood, Spleen, kidney, liver, lung, brain, intestine, heart

PLGA NPs significantly lowered the haematological, cardiac and testicular toxicity of the drug, but dose-dependent functional and morphological abnormalities were observed

Pereverzeva et al. [111]

Cx43MP peptide loaded PLGA nanoparticles

Nanoprecipitation technique–solvent evaporation

10–500 µg/mL

Zebrafish embryo toxicity (ZET) model

Embryos

Zebrafish remained normal 144 h after fertilization with the NPs; no significant malformations or cytotoxicity were obvious

Bisht and Rupenthal [17]

PLGA nanoparticles

Sonication method

100 μg/ml

BALB/c mice

Mouse cortical neuronal tissue

PLGA nanoparticles greatly protected neuronal cells against the aggregation of amyloid β (Aβ) peptide and showed favourable impact on the expression of AD-related genes/proteins

Wu et al. [148]

PLGA and PEG-PLGA nanoparticles

Sonication, solvent evaporation

1–25 µM

BALB/c mice

Frontal cortex from pup brains

PLGA nanoparticles inhibited β-amyloid (Aβ) peptides aggregation and triggered the disassembly of their aggregates beyond physiological temperatures, protecting neurons against Aβ-mediated toxicity

Paul et al. [109]